Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard M Stone

Showing results (151-160 of 420) with videos related to

Pageof 42
Sort By:
Blood|June 27, 2009
Granulocyte-macrophage colony-stimulating factor (GM-CSF)-secreting cellular immunotherapy in combination with autologous stem cell transplantation (ASCT) as postremission therapy for acute myeloid leukemia (AML)Ivan M Borrello, Hyam I Levitsky, Wendy Stock, et al.
Oncoimmunology|November 22, 2012
Detecting T-cell reactivity to whole cell vaccines: Proof of concept analysis of T-cell response to K562 cell antigens in CML patientsAna Brusic, Ursula Hainz, Martha Wadleigh, et al.
Leukemia & Lymphoma|July 16, 2020
Consensus minimum hemoglobin level above which patients with myelodysplastic syndromes can safely forgo transfusionsAnna M Tanasijevic, Anna Revette, Heidi D Klepin, et al.
Nature Immunology|September 15, 2021
Author Correction: Blockade of IL-22 signaling reverses erythroid dysfunction in stress-induced anemiasMahesh Raundhal, Shrestha Ghosh, Samuel A Myers, et al.
Leukemia Research|December 28, 2022
Intensity of induction regimen and outcomes among adults with Ph+ALL undergoing allogeneic hematopoietic stem cell transplantationHari S Raman, Se Eun Kim, Daniel J DeAngelo, et al.
Nature Immunology|March 23, 2021
Blockade of IL-22 signaling reverses erythroid dysfunction in stress-induced anemiasMahesh Raundhal, Shrestha Ghosh, Samuel A Myers, et al.
International Journal of Oncology|October 9, 2002
Isolated trisomy of chromosomes 8, 11, 13 and 21 is an adverse prognostic factor in adults with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B 8461Sherif S Farag, Kellie J Archer, Krzysztof Mrózek, et al.
Blood Advances|November 15, 2024
Venetoclax plus low-intensity chemotherapy for adults with acute lymphoblastic leukemiaMarlise R Luskin, Shai Shimony, Julia Keating, et al.
Molecular Cancer Therapeutics|June 6, 2019
Prognostic and Biologic Relevance of Clinically Applicable Long Noncoding RNA Profiling in Older Patients with Cytogenetically Normal Acute Myeloid LeukemiaDimitrios Papaioannou, Deedra Nicolet, Hatice G Ozer, et al.
Blood Advances|May 10, 2023
FLT3-ITD does not predict inferior prognosis in acute myeloid leukemia patients aged ≥60 yearsShai Shimony, Geoffrey Fell, Evan C Chen, et al.
Pageof 42

Showing results (151-160 of 420) with videos related to

Sort By:
Pageof 42
Blood|June 27, 2009
Granulocyte-macrophage colony-stimulating factor (GM-CSF)-secreting cellular immunotherapy in combination with autologous stem cell transplantation (ASCT) as postremission therapy for acute myeloid leukemia (AML)Ivan M Borrello, Hyam I Levitsky, Wendy Stock, et al.
Oncoimmunology|November 22, 2012
Detecting T-cell reactivity to whole cell vaccines: Proof of concept analysis of T-cell response to K562 cell antigens in CML patientsAna Brusic, Ursula Hainz, Martha Wadleigh, et al.
Leukemia & Lymphoma|July 16, 2020
Consensus minimum hemoglobin level above which patients with myelodysplastic syndromes can safely forgo transfusionsAnna M Tanasijevic, Anna Revette, Heidi D Klepin, et al.
Nature Immunology|September 15, 2021
Author Correction: Blockade of IL-22 signaling reverses erythroid dysfunction in stress-induced anemiasMahesh Raundhal, Shrestha Ghosh, Samuel A Myers, et al.
Leukemia Research|December 28, 2022
Intensity of induction regimen and outcomes among adults with Ph+ALL undergoing allogeneic hematopoietic stem cell transplantationHari S Raman, Se Eun Kim, Daniel J DeAngelo, et al.
Nature Immunology|March 23, 2021
Blockade of IL-22 signaling reverses erythroid dysfunction in stress-induced anemiasMahesh Raundhal, Shrestha Ghosh, Samuel A Myers, et al.
International Journal of Oncology|October 9, 2002
Isolated trisomy of chromosomes 8, 11, 13 and 21 is an adverse prognostic factor in adults with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B 8461Sherif S Farag, Kellie J Archer, Krzysztof Mrózek, et al.
Blood Advances|November 15, 2024
Venetoclax plus low-intensity chemotherapy for adults with acute lymphoblastic leukemiaMarlise R Luskin, Shai Shimony, Julia Keating, et al.
Molecular Cancer Therapeutics|June 6, 2019
Prognostic and Biologic Relevance of Clinically Applicable Long Noncoding RNA Profiling in Older Patients with Cytogenetically Normal Acute Myeloid LeukemiaDimitrios Papaioannou, Deedra Nicolet, Hatice G Ozer, et al.
Blood Advances|May 10, 2023
FLT3-ITD does not predict inferior prognosis in acute myeloid leukemia patients aged ≥60 yearsShai Shimony, Geoffrey Fell, Evan C Chen, et al.
Pageof 42